[go: up one dir, main page]

DE602004024236D1 - Assay - Google Patents

Assay

Info

Publication number
DE602004024236D1
DE602004024236D1 DE602004024236T DE602004024236T DE602004024236D1 DE 602004024236 D1 DE602004024236 D1 DE 602004024236D1 DE 602004024236 T DE602004024236 T DE 602004024236T DE 602004024236 T DE602004024236 T DE 602004024236T DE 602004024236 D1 DE602004024236 D1 DE 602004024236D1
Authority
DE
Germany
Prior art keywords
species
immobilised
binding
analyte
labelled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004024236T
Other languages
English (en)
Inventor
Balbir Raj
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere Switzerland GmbH
Original Assignee
Inverness Medical Switzerland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0328892A external-priority patent/GB0328892D0/en
Application filed by Inverness Medical Switzerland GmbH filed Critical Inverness Medical Switzerland GmbH
Publication of DE602004024236D1 publication Critical patent/DE602004024236D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
DE602004024236T 2003-12-12 2004-12-10 Assay Expired - Lifetime DE602004024236D1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0328892A GB0328892D0 (en) 2003-12-12 2003-12-12 Positive signal assay for analytes
US58511804P 2004-07-01 2004-07-01
PCT/GB2004/005146 WO2005059547A2 (en) 2003-12-12 2004-12-10 Assay

Publications (1)

Publication Number Publication Date
DE602004024236D1 true DE602004024236D1 (en) 2009-12-31

Family

ID=34702506

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004024236T Expired - Lifetime DE602004024236D1 (en) 2003-12-12 2004-12-10 Assay

Country Status (8)

Country Link
US (2) US7901949B2 (de)
EP (1) EP1706743B1 (de)
JP (1) JP4624364B2 (de)
AT (1) ATE449337T1 (de)
AU (1) AU2004298660B2 (de)
CA (1) CA2548164C (de)
DE (1) DE602004024236D1 (de)
WO (1) WO2005059547A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470608B2 (en) * 2008-05-20 2013-06-25 Rapid Pathogen Screening, Inc Combined visual/fluorescence analyte detection test
US8669052B2 (en) 2008-06-10 2014-03-11 Rapid Pathogen Screening, Inc. Lateral flow nucleic acid detector
GB0524746D0 (en) * 2005-12-03 2006-01-11 Inverness Medical Switzerland Assay device and method
CN101021526B (zh) * 2007-03-16 2012-01-25 艾博生物医药(杭州)有限公司 一种直观显示检测结果的装置和方法
US8609433B2 (en) 2009-12-04 2013-12-17 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with sample compressor
US20130196310A1 (en) 2008-05-20 2013-08-01 Rapid Pathogen Screening, Inc. Method and Device for Combined Detection of Viral and Bacterial Infections
US8815609B2 (en) 2008-05-20 2014-08-26 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with diverting zone
US8962260B2 (en) 2008-05-20 2015-02-24 Rapid Pathogen Screening, Inc. Method and device for combined detection of viral and bacterial infections
US9068981B2 (en) 2009-12-04 2015-06-30 Rapid Pathogen Screening, Inc. Lateral flow assays with time delayed components
US20110086359A1 (en) * 2008-06-10 2011-04-14 Rapid Pathogen Screening, Inc. Lateral flow assays
US9523701B2 (en) 2009-07-29 2016-12-20 Dynex Technologies, Inc. Sample plate systems and methods
GB0913258D0 (en) 2009-07-29 2009-09-02 Dynex Technologies Inc Reagent dispenser
US8088594B2 (en) * 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
WO2014014915A1 (en) 2012-07-16 2014-01-23 Centers For Disease Control And Prevention Direct reading detection kits for surface contamination by antineoplastic drugs
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
US9664700B2 (en) 2012-08-21 2017-05-30 Janssen Pharmaceutica Nv Antibodies to risperidone and use thereof
CA2882563C (en) * 2012-08-21 2022-11-29 Eric Hryhorenko Antibodies to risperidone haptens and use thereof
EP2888592B1 (de) 2012-08-21 2017-11-08 Janssen Pharmaceutica NV Antikörper gegen quetiapin und verwendung davon
CN110054693A (zh) * 2012-08-21 2019-07-26 詹森药业有限公司 喹硫平半抗原的抗体及其用途
ES2733963T3 (es) 2012-08-21 2019-12-03 Janssen Pharmaceutica Nv Anticuerpos contra haptenos de olanzapina y uso de los mismos
ES2822914T3 (es) 2012-08-21 2021-05-05 Janssen Pharmaceutica Nv Haptenos de aripiprazol y su uso en inmunoensayos
CA2882489A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone haptens and use thereof
PT2888590T (pt) 2012-08-21 2020-09-11 Janssen Pharmaceutica Nv Anticorpos para olanzapina e utilização destes
HK1211958A1 (en) 2012-08-21 2016-06-03 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone and use thereof
CN104736567B (zh) * 2012-08-21 2019-09-03 詹森药业有限公司 阿立哌唑半抗原的抗体及其用途
ES2762105T3 (es) 2012-08-21 2020-05-22 Janssen Pharmaceutica Nv Anticuerpos para aripiprazol y uso de los mismos
US10890590B2 (en) 2012-09-27 2021-01-12 Ellume Limited Diagnostic devices and methods
CN108051590B (zh) 2013-09-13 2020-12-11 Symbolics有限责任公司 运用二维试验和对照信号读出模式的侧向层析检测
EP3248001B1 (de) 2015-01-22 2019-09-18 Ellume Pty Ltd. Diagnostische vorrichtungen und verfahren zur abschwächung des hook-effekts und verwendung davon
CN111965343B (zh) * 2015-07-15 2023-05-09 格斯特维赛恩有限公司 用于检测错误折叠蛋白的装置及其使用方法
US10808287B2 (en) 2015-10-23 2020-10-20 Rapid Pathogen Screening, Inc. Methods and devices for accurate diagnosis of infections
CN108431040B (zh) 2015-12-17 2022-07-26 詹森药业有限公司 利培酮的抗体及其用途
US10435478B2 (en) 2015-12-17 2019-10-08 Janssen Pharmaceutica Nv Antibodies to quetiapine and use thereof
US10871485B2 (en) 2018-04-13 2020-12-22 Rarecyte, Inc. Kits for labeling of biomarkers and methods of using the same
GB201905090D0 (en) 2019-04-10 2019-05-22 Spd Swiss Prec Diagnostics Gmbh Assay device
CN112730825B (zh) * 2020-12-17 2022-09-06 北京丹大生物技术有限公司 一种用于检测利培酮和/或9-羟基利培酮的检测试剂和检测试剂盒

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0560411B1 (de) 1987-04-27 2000-07-26 Unilever N.V. Spezifische Bindungstestverfahren
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
GB8903627D0 (en) 1989-02-17 1989-04-05 Unilever Plc Assays
US5296347A (en) * 1991-02-08 1994-03-22 Ciba Corning Diagnostics Corp. Bridge immunoassay
EP0585310B1 (de) 1991-04-10 1999-03-17 Biosite Diagnostics Inc. "crosstalk"- oder übersprech-inhibitoren und ihre verwendung
US5451504A (en) 1991-07-29 1995-09-19 Serex, Inc. Method and device for detecting the presence of analyte in a sample
US6037127A (en) 1994-03-31 2000-03-14 E. I. Du Pont De Nemours And Company Method for detection of non-denatured nucleic acid fragments
WO1995027081A1 (en) * 1994-03-31 1995-10-12 E.I. Du Pont De Nemours And Company A method for detection of nucleic acid fragments
US5874216A (en) * 1996-02-23 1999-02-23 Ensys Environmental Products, Inc. Indirect label assay device for detecting small molecules and method of use thereof
ATE228247T1 (de) 1996-09-27 2002-12-15 Inverness Medical Switzerland Testreagentien und testvorrichtungen
SE9704933D0 (sv) * 1997-12-30 1997-12-30 Pharmacia & Upjohn Diag Ab Metod som utnyttjar en ny kalibrator och test kit som innehåller kalibratorn
US6753189B1 (en) 1998-06-04 2004-06-22 Mizuho Medy Co., Ltd. Detection apparatus and method for the same
US6414133B1 (en) * 1998-10-13 2002-07-02 Ventana Medical Systems, Inc. Multiple fusion probes
DE19927783A1 (de) * 1999-06-18 2000-12-21 Roche Diagnostics Gmbh Element zur Bestimmung eines Analyts in einer Flüssigkeit, entsprechendes Bestimmungsverfahren unter Verwendung des Elementes sowie Kit zur Bestimmugn eines Analyts
DE10009503A1 (de) * 2000-02-29 2001-08-30 Roche Diagnostics Gmbh Verfahren zur Immobilisierung von Konjugaten in diagnostischen Tests
US6699722B2 (en) * 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
US7029918B2 (en) * 2002-01-25 2006-04-18 Roche Diagnostics Operations, Inc. Water-soluble derivatives of lipophilic drugs
US8101429B2 (en) * 2003-06-03 2012-01-24 Siemens Healthcare Diagnostics Inc. Native analyte as a reference in lateral flow assays

Also Published As

Publication number Publication date
JP4624364B2 (ja) 2011-02-02
JP2007514157A (ja) 2007-05-31
EP1706743B1 (de) 2009-11-18
WO2005059547A3 (en) 2005-11-03
US20070015290A1 (en) 2007-01-18
EP1706743A2 (de) 2006-10-04
AU2004298660A1 (en) 2005-06-30
ATE449337T1 (de) 2009-12-15
CA2548164C (en) 2013-10-08
AU2004298660B2 (en) 2010-04-22
WO2005059547A2 (en) 2005-06-30
US7901949B2 (en) 2011-03-08
US20110223690A1 (en) 2011-09-15
CA2548164A1 (en) 2005-06-30
HK1099360A1 (en) 2007-08-10

Similar Documents

Publication Publication Date Title
DE602004024236D1 (en) Assay
MX2009004460A (es) Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
AU2002304640A1 (en) Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
ATE489625T1 (de) Chromatographische nachweisvorrichtung
NO20025371L (no) Forbedringer til fluorescense polymer-QTL tiln¶rming til biodetektering
GB2374415B (en) Human antibodies as detection reagents
DE60136034D1 (de) Molekular-Modifikations-Assays
WO2004041061A8 (en) Substrates, devices, and methods for cellular assays
ATE274699T1 (de) Analytassay-vorrichtung mit vorabsorbieren-zone
DE502005005132D1 (de) Verfahren zur erhöhung des dynamischen messbereichs von auf spezifischen bindereaktionen basierenden, insbesondere immunologischen testelementen
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
DE60333876D1 (de) Methoden zum Nachweis Analyten in Proben
EP1138781A3 (de) Methode zur Quantifizierung der Bindeaktivität von DNA-bindenden Proteinen
ATE405837T1 (de) Festphase immunochromatographische testverfahren
SE0301058D0 (sv) Method and kit for cell analyte assay
WO2004039963A8 (en) Antibodies specific for phosphorylated insulin receptor substrate-1/2 (ser 1101/ser1149) and uses thereof
WO2006071970A3 (en) Methods for the detection of analytes in a sample
WO2007076013A3 (en) Homocysteine immunoassay
ATE511650T1 (de) Verfahren zum nachweis von antikörpern einer bestimmten klasse über einen immunkomplex spezifischen antikörper
DK1057021T3 (da) Fremgangsmåde til måling af totalanalyt
DE59903720D1 (de) Rezeptorbindungsassays und reagenziensatz zum nachweis von tsh-rezeptor-autoantikörpern
WO2005079420A3 (en) Chromatographic exclusion agglutination assay and methods of use thereof
DK1257823T3 (da) Fremgangsmåde til påvisning af Helicobacter pylori og heilmanii
ATE484748T1 (de) Testverfahren zur bestimmung von analyten mittels analytanalogen
RU2008130888A (ru) Мас-2вр как маркер для диагностики рака желудка

Legal Events

Date Code Title Description
8364 No opposition during term of opposition